Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas

Pathology

Volumn 33, Issue 3, 2001, Pages 287-291

  Dahlstrom, Jane E ^a   Maxwell, Lesley E ^a   Brodie, Narelle ^a   Zardawi, Ibraham M ^b   Jain, Sanjiv ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Hampson Pathology   (Australia)

Author keywords

Adenocarcinoma; Electron microscopy; HBME 1; Immunogold; Immunohistochemistry; Lung; Mesothelioma; Pleura

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HBME1; UNCLASSIFIED DRUG;

ARTICLE; BRUSH BORDER; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DILUTION; HUMAN; HUMAN TISSUE; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MICROVILLUS; PLEURA MESOTHELIOMA;

EID: 0034910791     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020126322     Document Type: Article

References (23)

1. The pleura
2. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma
3. The histopathological diagnosis of malignant mesothelioma v pulmonary adenocarcinoma: Reproducibility of the histological diagnosis
4. Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma
5. The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma
6. The immunohistochemical diagnosis of epithelial mesothelioma
7. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours
8. Malignant mesothelioma: Ultrastructural distinction from adenocarcinoma
9. The immunohistochemistry of malignant mesothelioma
10. Diagnostic histochemical and immunohistochemical studies in malignant mesothelioma
11. The immunohistochemical diagnosis of mesothelioma
12. Mesothelioma-binding antibodies: Thrombomodulin, OV 632 and HMBE-1 and their use in the diagnosis of malignant mesothelioma
13. The value of antibodies 44-3A6, SM3, HBME-1, and Thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma
14. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma
15. Utility of HBME-1 immunostaining in serous effusions
16. Immunohistochemical phenotype of malignant mesothelioma: Predictive value of CA125 and HBME-1 expression
17. Newly marketed tissue markers for malignant mesothelioma: Immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies
18. HBME-1 a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft tissue and bone tumours
19. The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat-induced epitope retrieval
20. E-cadherin and calretinin: A useful combination of immunohistochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma
21. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: Comparison with quantitative biochemical methods